Identification of Cubebin from Cubeb (Piper cubeba) as An Antiplatelet Agent

http://www.doi.org/10.26538/tjnpr/v7i7.17

Authors

  • Kyky Herlyanti Department of Pharmacy, Sekolah Tinggi Ilmu Farmasi Yayasan Pharmasi, Semarang 50193, Indonesia
  • Nanang Fakhrudin Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara, Yogyakarta 55281, Indonesia
  • Retno Murwanti Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara, Yogyakarta 55281, Indonesia
  • Wahyono Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara, Yogyakarta 55281, Indonesia

Keywords:

platelet aggregation, cardiovascular diseases, medicinal plant, Piper cubeba

Abstract

Platelets play a key role in arterial thrombosis. Platelet aggregation is part of a sequential mechanism leading to the formation of a thrombus. Antiplatelet agent is needed for the inhibition of platelet aggregation. Piper cubeba or Cubeb is an Indonesian traditional herbal medicine. Cubeb fruit is rich in lignans, such as cubebin, hinokinin, clusin, dihydrocubebin, dihydroclusin, cubebinin, yatein, cubbinulide (cordigerine), dihydroyatein, isoyatein, and cubebinone. Previous studies have indicated that several lignans exert antiplatelet activity. Additionally, the extract of Piper cubeba fruit exhibits antiplatelet activity. This study aimed to evaluate the antiplatelet activities of P. cubeba fruit fractions and identify active compound. The fruit was macerated in ethanol for 5 days. The extract was fractionated by vacuum liquid chromatography (using dichloromethane with ethylacetate added in a polar gradient. The main compound was isolated and identified based on its infrared, H-nuclear magnetic resonance, (H-NMR), C-NMR, and mass spectra. The antiplatelet activity was determined by an in vitro antiplatelet aggregation assay employing human platelets induced with several platelet receptor agonists Adenosine Diphosphate (ADP), epinephrine, thrombin, and arachidonic acid). The ethanol extract of P. cubeba fruit and its fractions demonstrated antiplatelet activity induced by epinephrine, ADP, thrombin, arachidonic acid and ristocetin. The major compound in the active fraction was identified as cubebin. Cubebin demonstrated antiplatelet activity in platelet aggregation induced by thrombin with the IC50 of 14.62±1.16 µM. Cubebin is a novel antiplatelet agent isolated from P. cubeba.

Author Biographies

Kyky Herlyanti, Department of Pharmacy, Sekolah Tinggi Ilmu Farmasi Yayasan Pharmasi, Semarang 50193, Indonesia

Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara, Yogyakarta 55281, Indonesia

Nanang Fakhrudin, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara, Yogyakarta 55281, Indonesia

Medicinal Plants and Natural Products Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara, Yogyakarta 55281, Indonesia

Retno Murwanti, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara, Yogyakarta 55281, Indonesia

Medicinal Plants and Natural Products Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara, Yogyakarta 55281, Indonesia

References

Gaspar RS, Da Silva SA, Stapleton J, De Lima Fontelles JL, Sousa HR, Chagas VT, Alsufyani S, Trostchansky A, Gibbins JM, De Andrada Paes AM. Myricetin, the main

flavonoid in syzygium cumini leaf, is a novel inhibitor of platelet thiol isomerases PDI and ERp5. Front Pharmacol. 2020;10.

Chung C-L, Chen J-H, Huang W-C, Sheu JR, Hsia CW, Jayakumar T, Hsia CH, Chiou KR, Hou SM. Glabridin, a Bioactive Flavonoid from Licorice, Effectively Inhibits

Platelet Activation in Humans and Mice. Int J Mol Sci 2022; 23(19):11372.

Herath TD, Paturi G, Butts CA, Sansom CE, Morgenstern MP. In vitro and in vivo effects of carrot on human blood platelet aggregation. Int J Food Sci Technol. 2021;

(4):1829–36. 09

Duttaroy AK. Tomato Extract and Human Platelet Functions. Nutraceuticals Hum Blood Platelet Funct. 2018; 101–23.

Guo Q, Li B, Bao C, Li Y, Cao Y, Wang C, Wu W. Bletilla striata Polysaccharides Improve Hemostatic, Antiinflammatory Efficacy, and Platelet Aggregation in

Gingivitis Rat Model. Starch - Stärke. 2021; 73(3– 4):2000185.

Gutiérrez-Herrero S, Fernández-Infante C, Hernández-Cano L, Ortiz-Rivero S, Guijas C, Martín-Granado V, Ramon Gonzales-Pora J, Balsinde J, Porras A, Guerrero C. C3G

contributes to platelet activation and aggregation by regulating major signaling pathways. Signal Transduct Target Ther 2020 51. 2020; 5(1):1–15.

Manjuprasanna VN, Urs AP, Rudresha G V., Milan Gowda MD, Jayachandra K, Hiremath V, Rajaiah R, Vishwanath BS. Drupin, a thrombin-like protease prompts platelet

activation and aggregation through protease-activated receptors. J Cell Biochem. 2021; 122(8):870–81.

Kojok K, El-Kadiry AEH, Merhi Y. Role of NF-κB in Platelet Function. Int J Mol Sci. 2019; 20(17).

Frontroth JP, Favaloro EJ. Ristocetin-induced platelet aggregation (RIPA) and RIPA mixing studies. Methods Mol Biol. 2017; 1646:473–94.

Miller CH. Laboratory Diagnosis of Inherited vonWillebrand Disease. Transfus Med Hemost. 2019;799–805.

Dembitsky VM, Gloriozova TA, Poroikov VV, Koola MM. QSAR Study of Some Natural and Synthetic Platelet Aggregation Inhibitors and their Pharmacological Profile

ARTICLE INFO. J Appl Pharm Sci. 2022; 12(05):39–058.

Yoon SS, Kwon HW, Shin JH, Rhee MH, Park CE, Lee DH. Anti-Thrombotic Effects of Artesunate through Regulation of cAMP and PI3K/MAPK Pathway on Human Platelets. Int

J Mol Sci. 2022; 23(3):1586.

Kornfeld M, Munsayac JR. Antiplatelet Medications. Inpatient Anticoagulation. 2022; 47–65.

Fakhrudin N, Pertiwi KK, Takubessi MI, Susiani EF, Nurrochmad A, Widyarini S, et al. A geranylated chalcone with antiplatelet activity from the leaves of breadfruit

(Artocarpus altilis). Pharm. 2020; 67(4):173–80.

Ngo T, Kim K, Bian Y, Noh H, Lim KM, Chung JH, Bae ON. Antithrombotic Effects of Paeoniflorin from Paeonia suffruticosa by Selective Inhibition on Shear Stress-Induced

Platelet Aggregation. Int J Mol Sci. 2019; 20(20):5040.

Nwaogu LA, Igwe CU, Iwueke A V., Chukwudoruo CS. In Vitro Aggregation Inhibition Activity of n-Hexane Leaf Extract of Azadirachta indica of Human Platelet. Trop J Nat

Prod Res. 2022;6(9):1487–91.

Kim K, Park K Il. A Review of Antiplatelet Activity of Traditional Medicinal Herbs on Integrative Medicine Studies. Evid Based Complement Alternat Med. 2019.

Rojas-García A, Rodríguez L, Cádiz-Gurrea M de la L, García-Villegas A, Fuentes E, Villegas-Aguilar M del C, Palomo I, Arraez-Roman D, Segura-Carretero A.

Determination of the Bioactive Effect of Custard Apple ByProducts by In Vitro Assays. Int J Mol Sci. 2022; 23(16):9238.

Ester M, Model LP, Umar M. Dioscorea prehensilis Ameliorates the Features of Preeclampsia in L-N G - Nitroarginine. Tropical Journal of Natural Product Research.

;2(4)22–8.

WHO. WHO traditional medicine strategy: 2014-2023. 2013

Herlyanti K, Murwanti R, Wahyono, Fakhrudin N. Antiplatelet Activity of Piper cubeba Fruit Ethanol Extract. Trop J Nat Prod Res. 2022; 6(11):1832–5.

Elfahmi, Ruslan K, Batterman S, Bos R, Kayser O, Woerdenbag HJ, et al. Lignan profile of Piper cubeba, an Indonesian medicinal plant. Biochem Syst Ecol. 2007;

(7):397–402.

Godoy de Lima R, Barros MT, da Silva Laurentiz R. Medicinal Attributes of Lignans Extracted from Piper Cubeba: Current Developments. Chemistryopen. 2018;

(2):180–91.

Rajalekshmi DS, Kabeer FA, Madhusoodhanan AR, Bahulayan AK, Prathapan R, Prakasan N, et al. Anticancer activity studies of cubebin isolated from Piper cubeba and its

synthetic derivatives. Bioorganic Med Chem Lett. 2016;26(7):1767–71.

Park BS, Son DJ, Park YH, Kim TW, Lee SE. Antiplatelet effects of acidamides isolated from the fruits of Piper longum L. Phytomedicine. 2007; 14(12):853–5.

Chen YC, Liao CH, Chen IS. Lignans, an amide and antiplatelet activities from Piper philippinum. Phytochemistry. 2007; 68(15):2101–11.

Glauce D, Viana SB, Fontenele JB, Kalyne L, Leal AM, Silveira ER, Felix FH, Felipe CFB. Antiplatelet effects of piplartine, an alkamide isolated from Piper tuberculatum:

possible involvement of cyclooxygenase blockade and antioxidant activity. J Pharm Pharmacol. 2010; 61(4):511–5.

Son DJ, Akiba S, Hong JT, Yun YP, Hwang SY, Park YH, et al. Piperine Inhibits the Activities of Platelet Cytosolic Phospholipase A2 and Thromboxane A2 Synthase without

Affecting Cyclooxygenase-1 Activity: Different Mechanisms of Action Are Involved in the Inhibition of Platelet Aggregation and Macrophage Inflammatory

Response. Nutr. 2014; 6(8):3336–52.

Macedo AL, Martorano LH, de Albuquerque ACF, Fiorot RG, Carneiro JWM, Campos VR, Vasconcelos TRA, Valverde AL, Moreira DL, dos Santos FM. Absolute

Configuration of (−)-Cubebin, a Classical Lignan with Pharmacological Potential, Defined by Means of Chiroptical Spectroscopy. J Braz Chem Soc. 2020 Oct 9; 31(10):2030–

Rezende KCS, Lucarini R, Símaro G V., Pauletti PM, Januário AH, Esperandim VR, , Martins CHG, Silva MA, Cunha WR, Bastos JK, Siilva MLAE. Antibacterial activity

of (−)-cubebin isolated from Piper cubeba and its semisynthetic derivatives against microorganisms that cause endodontic infections. Rev Bras Farmacogn. 2016;

(3):296–303.

Wahyono W, Wahyuono S, Mursyidi A, Timmerman H, Verpoorte R, Hakim L. Identification of cubebin and epicubebin isolated from Piper cubeba L.f fruits with two DNMR spectroscopy. Indones J Pharm. 2005; 0(0):232–8.

Siddiqui ZN, Khuwaja G, Ahmad J. Antifungal activity of Cubebin from Piper cubeba. J Indian Chem Soc. 2007;84(8):823–4.

Bastos JK, Carvalho JCT, De Souza GHB, Pedrazzi AHP, Sarti SJ. Anti-inflammatory activity of cubebin, a lignan from the leaves of Zanthoxyllum naranjillo Griseb. J

Ethnopharmacol. 2001; 75(2–3):279–82.

Niwa AM, De Paula NA, Vesenick DC, Sartori D, Maistro EL, Ribeiro LR, Mantovani MS. Evaluation of lignan (-)- cubebin extracted from Piper cubeba on human colon

adenocarcinoma cells (HT29). J Toxicol Environ Heal - Part A Curr Issues. 2016; 79(2):92–100.

Published

2023-07-31

How to Cite

Herlyanti, K., Fakhrudin, N., Murwanti, R., & Wahyono. (2023). Identification of Cubebin from Cubeb (Piper cubeba) as An Antiplatelet Agent: http://www.doi.org/10.26538/tjnpr/v7i7.17. Tropical Journal of Natural Product Research (TJNPR), 7(7), 3392–3397. Retrieved from https://www.tjnpr.org/index.php/home/article/view/2229